PL, thanks for the FYI. I'm aware of Dew's "regard" for PPHM, and the last opinion I remember reading from him about it was that PPHM didn't have anything that BP/BB wanted. I agree with him that nobody wanted Oncolym nor (so far) Cotara (nor VEA or VTA technology), but with these anti-PS Antibodies I sense that that may be about to change. We should find out this year.
Market Data 
Markets 
AI
